1[1]Maury E,Hochberg M,Cassell S,et al.Rheumatoid arthritis patients on TNF blockers have higher rates of infections.Arthritis Rheum,2005,52 (Suppl):S547-S548
2[2]Dixon W,Watson K,Hyrich K,et aL The incidence of serious infections is not increased in patients with rheumatoid arthritis treated with anti-TNF drugs compared to those treated with traditional DMARDs:results from anational prospective study.Arthritis Rheum,2005,52 (Suppl):S738
3[3]Kenneth G.Sang,Gim Gee Teng,Nivedita M.Patkar,et al.American College of Rheumatology 2008 Recommendations for the Use of Nonbiolngic and Biologic Disease Modifying Antirheumatic Drugs in Rheumatoid Arthritis.Arthritis & Rheumatism (Arthritis Care & Research),2008,59(6):762-784
4[4]Wallis RS,Kyambadde P,Johnson JL,et al.A study of the safety,immunology,virology,and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis.Aids,2004,18:257-264
5[5]Mohan VP,Scanga CA,Yu K,et al.Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis:possible role for limiting pathology.Infect Immun,2001,69:1847-1855
6[6]Askling J,Fored CM,Brandt L,et al.Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden.Arthritis Rheum,2005,52:1986-1992
7[7]Gomez-Reino JJ,Carmona L,Angel Descalzo M.Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection.Arthritis Rheum,2007,57:756-761
8[8]Carmona L,Gomez-Reino JJ,Rodriguez-Valverde V,et al.Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists.Arthritis Rheum,2005,52:1766-1772
9[9]Askling J,Fored CM,Baecklund E,et al.Haematopoietic malignancies in rheumatoid arthritis:lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists.Ann RheumDis,2005,64:1414-1420
10[10]Setoguchi S,Solomon DH,Weinblatt ME,et al.Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis.Arthritis Rheum,2006,54:2757-2764
4Efthimiou P,Paik PK,Bielory L.Diagnosis and management of adult onset Still'S disease[J].Ann Rheum Dis,2006,65:564-572.
5Kadar J,Petrovicz E.Adult-onset Still'S disease[J].Beat Pract Res Clin Rheurnatol,2004,18:663-676.
6GUIPCAR Group.Clinical practice guideline for the management of rheumatoid arthritis in Spain[J].Madrid:Spanish Society of Rheumatology,2007,301.
7Reginato AJ,Schumacher HR Jr,Baker DG,el al.Adult onset Still'S disease:experience in 23 patients and literature review with emphasis on organ failure[J].Semin Arthritis Rheum,1987,17:39-57.
8Owlia MB,Mehrpoor G.A dult-onset Stilll'S disease:A review[J].Inthan J Mod Sci,2009,63:207-221.
9Kontziasl A,Efthimiou P.Adult-onset Still'S disease:pathogenesis,clinical manifestations and therapeutic advances[J].Drugs,2008,68(3):319-337.
